A detailed history of Redwood Park Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Redwood Park Advisors LLC holds 699 shares of AMGN stock, worth $238,855. This represents 0.13% of its overall portfolio holdings.

Number of Shares
699
Previous 749 6.68%
Holding current value
$238,855
Previous $209 Million 5.69%
% of portfolio
0.13%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$271.18 - $309.22 $13,559 - $15,461
-50 Reduced 6.68%
699 $197 Million
Q2 2025

Aug 01, 2025

BUY
$262.28 - $309.85 $262 - $309
1 Added 0.13%
749 $209 Million
Q1 2025

May 06, 2025

BUY
$258.59 - $327.36 $1,292 - $1,636
5 Added 0.67%
748 $233 Million
Q4 2024

Feb 13, 2025

BUY
$258.78 - $328.31 $192,273 - $243,934
743 New
743 $194 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Redwood Park Advisors LLC Portfolio

Follow Redwood Park Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Park Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Park Advisors LLC with notifications on news.